1 |
Lusis AJ. Atherosclerosis [J]. Nature, 2000, 407(6801): 233-241.
|
2 |
Huh JY, Park YJ, Ham M, et al. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity [J]. Mol Cells, 2014, 37(5): 365-371.
|
3 |
Qi XY, Qu SL, Xiong WH, et al. Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword [J]. Cardiovasc Diabetol, 2018,17(1):134.
|
4 |
Cai M, Zhao D, Han X, et al. The role of perivascular adipose tissuesecreted adipocytokines in cardiovascular disease [J]. Frontiers in immunology, 2023, 14: 1271051.
|
5 |
Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue [J]. Br J Nutr, 2004, 92(3):347-355.
|
6 |
DMarco L, Puchades MJ, Gorriz JL, et al. Epicardial adipose tissue,adiponectin and leptin: A potential source of cardiovascular risk in chronic kidney disease [J]. Int J Mol Sci, 2020, 21(3): 978-991.
|
7 |
刘慧, 白冰. 血管周围脂肪组织与心血管疾病的关系 [J]. 心血管病学进展, 2018, 39(04): 640-643.
|
8 |
Cedikova M, Kripnerová M, Dvorakova J, et al. Mitochondria in White, Brown, and Beige Adipocytes [J]. Stem Cells Int , 2016,2016:6067349.
|
9 |
Adamczak M, Wiecek A. The adipose tissue as an endocrine organ [J].Semin Nephrol, 2013, 33(1):2-13.
|
10 |
Cittadini A, Mantzoros CS, Hampton TG, et al. Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity [J]. Circulation, 1999, 100(21): 2177-2183.
|
11 |
Takx RA, Ishai A, Truong QA, et al. Supraclavicular brown adipose tissue 18F-FDG uptake and cardiovascular disease [J]. J Nucl Med,2016, 57(8): 1221-1225.
|
12 |
Odermatt TS, Dedual MA, Borsigova M, et al. Adipocyte-specific GP130 signalling mediates exercise-induced weight reduction [J]. Int J Obes( Lond), 2020, 44(3):707-714.
|
13 |
程龙, 朱耀萱, 周晶, 等. 冷暴露对高脂饮食小鼠脂肪棕色化的影响[J]. 中国药理学通报, 2019, 35(6):802-809.
|
14 |
Finlin BS, Memetimin H, Confides AL, et al. Human adipose beiging in response to cold and mirabegron [J]. JCI Insight, 2018,3(15):e121510.
|
15 |
Zhang Z, Cui Y, Su V, et al. A PPARγ/long noncoding RNA axis regulates adipose thermoneutral remodeling in mice [J]. J Clin Invest,2023,133(21):e170072.
|
16 |
Miranda CS, Silva-Veiga FM, Santana-Oliveira DA, et al. PPARα/γ synergism activates UCP1-dependent and -independent thermogenesis and improves mitochondrial dynamics in the beige adipocytes of highfat fed mice [J]. Nutrition, 2024, 117:112253.
|
17 |
Kraakman MJ, Liu Q, Postigo-Fernandez J, et al. PPARgamma deacetylation dissociates thiazolidinedione's metabolic benefits from its adverse effects [J]. J Clin Invest, 2018, 128(6): 2600-2612.
|
18 |
Wu D, Eeda V, Undi RB, et al. A novel peroxisome proliferatoractivated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice [J]. Mol Metab, 2021, 54: 101363.
|
19 |
Chen X, Yang L, Zhai SD. Risk of cardiovascular disease and allcause mortality among diabetic patients prescribed rosiglitazone or pioglitazone: a meta-analysis of retrospective cohort studies [J]. Chin Med J (Engl), 2012, 125(23): 4301-4306.
|
20 |
Juurlink DN, Gomes T, Lipscombe LL, et al. Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study [J]. BMJ, 2009, 339: b2942.
|
21 |
Tiraby C, Langin D. PGC-1alpha, a transcriptional coactivator involved in metabolism [J]. Med Sci (Paris), 2005, 21(1): 49-54.
|
22 |
Grzeszczuk M, Dziegiel P, Nowińska K. The role of FNDC5/Irisin in cardiovascular disease [J]. Cells, 2024, 13(3): 277.
|
23 |
聂永伟. 鸢尾素的定位机制及其功能研究 [D]. 呼和浩特: 内蒙古大学, 2016.
|
24 |
Seale P, Bjork B, Yang W, et al. PRDM16 controls a brown fat/skeletal muscle switch [J]. Nature, 2008, 454(7207): 961-967.
|
25 |
Cohen P, Levy JD, Zhang Y, et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch [J]. Cell, 2014, 156(1-2): 304-316.
|
26 |
Kajimura S, Seale P, Kubota K, et al. Initiation of myoblast to brown fat switch by a PRDM16 -C/EBP-beta transcriptional complex [J].Nature, 2009, 460(7259): 1154-1158.
|
27 |
Seale P, Kajimural S, Yang W, et al. Transcriptional control of brown fat determination by PRDM16 [J]. Cell Metab, 2007, 6(1): 38-54.
|
28 |
Guo B, Liu J, Wang B, et al. Withaferin A promotes white adipose browning and prevents obesity through sympathetic nerve-activated prdm16-FATP1 axis [J]. Diabetes, 2022, 71(2): 249-263.
|
29 |
Timmons JA, Wennmalm K, Larsson O, et al. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages [J]. Proc Natl Acad Sci USA,2007, 104(11): 4401-4406.
|
30 |
郑晓彬, 艾鹤英, 袁淑华, 等. SIRT1 基因缺陷对肥胖小鼠棕色脂肪功能的影响 [J]. 中华医学杂志, 2016, 96 (23): 1859-1862.
|
31 |
陶璐, 初楠, 韩洁, 等. 血清PECAM-1、Sirt1 水平与2 型糖尿病患者颈动脉粥样硬化的关系 [J/OL]. 中华临床医师杂志(电子版),2023, 17(3): 291-296.
|
32 |
李博涵. 靶向脂肪组织AMPK 调控能量代谢与抗肥胖作用研究[D]. 北京: 中国科学院大学, 2020.
|
33 |
Mottillo EP, Desjardins EM, Crane JD, et al. Lack of adipocyte AMPK exacerbates insulin resistance and hepatic steatosis through brown and beige adipose tissue function [J]. Cell Metab, 2016, 24(1): 118-129.
|
34 |
Bondurant LD, Potthoff MJ. Fibroblast growth factor 21: a versatile regulator of metabolic homeostasis [J]. Annual Rev Nutrit, 2018, 38:173-196.
|
35 |
Zhang L, Cai X, Ma F, et al. Two-step regulation by matrix Gla protein in brown adipose cell differentiation [J]. Mol Metab, 2024, 80: 101870.
|
36 |
Mu WJ, Song YJ, Yang LJ, et al. Bone morphogenetic protein 4 in perivascular adipose tissue ameliorates hypertension through regulation of angiotensinogen [J]. Front Cardiovasc Med, 2022,9: 1038176.
|
37 |
李萍, 周颖, 栾剑威, 等. 基于“卫气理论”探讨膏脂与血管周围脂肪组织的相关性 [J]. 湖南中医药大学学报, 2022, 42(11): 1948-1952.
|
38 |
王雨涵, 刘福明. 基于"脉损"学说辨治早期动脉粥样硬化 [J]. 北京中医药大学学报, 2023, 46(2): 186-190.
|
39 |
伍迪. 二氢杨梅素促进WAT 棕色化抵抗高脂饮食诱导的肥胖 [D].湖南衡阳, 南华大学, 2018.
|
40 |
白继昌, 谈力欣, 刘赞朝, 等. 葛根素对3T3-L1 脂肪细胞胰岛素抵抗的影响及机制研究[J]. 广西医科大学学报, 2024, 41(1): 40-45.
|
41 |
吕香州, 魏铭宏, 吴思惠, 等. 葛根素对松辽黑猪前体脂肪细胞成脂分化的影响 [J]. 中国畜牧兽医, 2021, 48(12): 4422-4428.
|
42 |
Andradejm O, Barcala Jorge AS, Batista-Jorge GC, et al. Effect of resveratrol on expression of genes involved thermo-genesis in mice and humans [J]. Biomed Pharmacother, 2019(112): 108634.
|
43 |
Zhang Z, Zhang H, Li B, et al. Berberine activates thermogenesisin white and brown adipose tissue [J]. Nat Commun, 2014, (5): 5493.
|
44 |
Lee E, Jung DY, Kim JH, et al. Transient receptor potentialvanilloid type4 channel regulates diet-induced obesity, insulinresistance, and leptin resistance [J]. FASEB J, 2015, 29(8): 3182-3192.
|
45 |
Fan L, Xu H, Yang R, et al. Combination of capsaicin and capsi-ate induces browning in 3T3 -Ll white adipocytes via activationof the peroxisome proliferator -activated receptor y/β(3)-ad-renergic receptor signaling pathways [J]. Journal of agricultural andfood chemistry,2019, 67(22): 6232-6240.
|
46 |
乔羽, 张京春, 刘玥, 等. 人参-川芎有效成分通过PPARγ/PGC-1α/UCP1 通路调控白色脂肪棕色化的机制研究 [J]. 中草药, 2022,53, (2): 478-483.
|
47 |
Lee K, Seo YJ, Song JH, et al. Ginsenoside Rgi promotesbrowning by inducing UCP¹expression and mitochondrial activ-ity in 3T3-L1 and subcutaneous white adipocytes [J]. J Ginseng Res, 2019, 43(4):589-599.
|
48 |
Park SJ, Park M, Sharma A, et al. Black ginseng and ginse-noside Rb1 promote browning by inducing UCP¹expression in3T3-L1 and primary white adipocytes [J]. Nutrients, 2019, 11(11): 2747.
|
49 |
Ma L, Zhao Z, Guo X, et al. Tanshinone ⅡA and its deriva-tive activate thermogenesis in adipocytes and induce “beiging” of white adipose tissue [J]. Mol Cell Endocrinol, 2022, 544: 111557.
|
50 |
Wang YJ, Huang SL, Feng Y, et al. Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor,regulatesadipocyte function in vitro and exerts anti-diabetic effect in ob/obmice [J]. Acta Pharmacol Sin,2012, 33(9): 1195-1203.
|
51 |
宋冰, 刘学政. 大黄素对KKAy 糖尿病小鼠脂肪组织PPAR-α 及PPAR-γ 表达影响的实验研究 [J]. 北京中医药大学学报, 2012,35(10): 692-695.
|
52 |
程龙, 董世芬, 袁悦莹, 等. 大黄素对ApoE 基因敲除小鼠脂肪棕色化的影响 [J]. 中国比较医学杂志, 2018, 28(11): 8-14.
|
53 |
张世和. 黄芪多糖对C3H10T 1/2 细胞棕色脂肪分化的影响 [D]. 晋中: 山西农业大学, 2021.
|
54 |
Chou YJ, Kan WC, Chang CM, et al. Renal protective effects of low molecular weight of inonotus obliquus polysaccharide (LIOP) on HFD/STZ-induced nephropathy in mice [J]. Int J Mol Sci, 2016, 17(9):1535.
|
55 |
吴洁. 桦树茸提取物改善小鼠肥胖的作用机制及抗糖尿病作用研究 [D]. 郑州: 郑州大学, 2020.
|
56 |
陈青扬, 黄惠勇, 刘卜菡. 加味生脉补心丹对防治2 型糖尿病大鼠心肌损害的影响 [J].湖南中医药大学学报, 2016, 36(3): 5-8.
|
57 |
鲁丽君. 生脉注射液治疗108 例糖尿病合并冠心病疗效观察 [J].中国药物与临床, 2010, l0(10):1157-1158.
|
58 |
叶佐武, 徐金波, 鲁春芳, 等. 生脉饮调控STZ 诱导糖尿病大鼠心肌脂质代谢作用机制研究 [J]. 浙江中西医结合杂志, 2018, 28(7):537-541.
|
59 |
Liu X, Wang S, Wu Z, et al. Deoxyschizandrin loadedliposomes on the suppression lipid accumulation in 3T3-L1 adipocytes [J]. Molecules,2018, 23(9): 2158.
|
60 |
Zhu PL, Pan SY, Zhou SF, et al. Effects of combineddietary supplementation with fenofibrate and Schisandrae Fructuspulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice [J]. Drug Des Dev Ther, 2015, 9: 923-935.
|
61 |
何慧玲, 董敏健, 康敏, 等. 党参中过氧白术内酯Ⅲ的提取分离及促进脂解的机制研究 [J]. 遵义医科大学学报, 2022, 45(5): 559-566.
|
62 |
Tian Y, Gong P, Wu Y, et al. Screening and identification of potential active components in Ophiopogonis Radix against atherosclerosis by biospecific cell extraction [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2019, 1133: 121817.
|
63 |
方佳. 基于代谢组学和肠道菌群分析探讨麦冬寡糖抗2 型糖尿病的作用机制 [D]. 广州: 广州中医药大学, 2021.
|
64 |
张小清, 许文华, 肖鑫, 等. 葛根芩连汤促进糖尿病大鼠棕色脂肪分化改善糖脂紊乱的分子机制 [J]. 中国中药杂志, 2021, 46(17):4462-4470.
|
65 |
张小清. 葛根芩连汤促进脂肪能量代谢改善糖脂紊乱的分子机制[D]. 南昌: 江西中医药大学, 2021.
|
66 |
王琳琳, 胡可佳. 葛根芩连汤对肥胖小鼠的脂质代谢的作用及其机制研究 [J]. 世界中西医结合杂, 2021, 16(7): 1231-1236.
|
67 |
吴云起, 唐汉庆, 吴翠松, 等. 脾阳虚证大鼠棕色脂肪组织和解偶联蛋白1 关联性的研究 [M]. 中国中医科学院中药研究所; 中国中西医结合学会中药专业委员会, 2011.
|
68 |
彭凯夫. 黄连温胆汤对2 型糖尿病小鼠白色脂肪棕色化以及脂肪中PI3K/ AKT 通路表达的影响 [D]. 成都: 成都体育学院, 2021.
|
69 |
任美玲. 温胆汤对肥胖痰湿证模型大鼠棕色脂肪脂质代谢相关基因UCP1 启动子甲基化及其表达的影响 [D]. 南昌: 江西中医药大学, 2023.
|
70 |
于澄元. 碧生源牌茯苓泽泻片减肥作用健脾利湿功效及其机制研究 [D]. 天津: 天津中医药大学, 2023.
|
71 |
丁婧, 赵洁, 王萌萌, 等. 基于GLP-1R/cAMP/PKA/CREB 的泽泻汤促进白色脂肪棕色化/激活棕色脂肪作用机制研究 [J]. 中国中药杂志, 2023, 48(21): 5851-5862.
|
72 |
Zhang X, Zhang QX, Wang X, et al. Dietary luteolin activates browning and thermogenesis in mice through an AMPK/PGCla pathway-mediated mechanism [J]. Int JObes (Lond), 2016, 40(12):1841-1849.
|
73 |
刘瑶瑶, 阎博华. 从白色脂肪棕色化及棕色脂肪活化角度探讨肥胖温阳中药的应用 [J]. 中华中医药杂志, 2022, 37(2): 947-950.
|
74 |
于澄元, 樊薛津, 庄朋伟, 等. 植物雌激素类中药诱导白色脂肪组织棕色化的研究进展[J]. 中南药学, 2023, 21(1): 161-168.
|